Hirotoshi Kobayashi
Papers
2
Total Citations
15
H-Index
2
About
Dr. Hirotoshi Kobayashi is a pioneering surgeon at the forefront of robotic oncology, specializing in minimally invasive treatments for gastric cancer and peritoneal surface malignancies. His landmark 2023 study on Indocyanine Green (ICG) tracer-guided radical robotic distal gastrectomy using the Firefly™ system demonstrated a significant leap in surgical precision, showing that real-time fluorescence imaging markedly improves the quality of lymph node dissection in gastric cancer patients—a contribution that has already garnered 13 citations for its clinical impact. Expanding the boundaries of robotic surgery, Dr. Kobayashi’s 2024 pilot study established the feasibility of robot-assisted cytoreductive surgery with upper-abdominal peritonectomy for pseudomyxoma peritonei in patients with low peritoneal carcinomatosis indices, offering a less invasive alternative to traditional open procedures. His work is characterized by a relentless drive to validate novel robotic techniques through rigorous clinical evidence, directly translating technological innovation into improved patient outcomes. As a leader in robotic surgical oncology, Dr. Kobayashi continues to shape the future of cancer care, inspiring a new generation of surgeons to embrace precision, safety, and innovation.
Research Focus
Key Achievements
Top Papers
- 1
- 2